HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,129,335 | +518.2% | 122,131 | +449.6% | 0.11% | +535.3% |
| Q2 2023 | $2,285,636 | +139098.3% | 22,223 | +47.7% | 0.02% | +30.8% |
| Q1 2023 | $1,642 | -71.3% | 15,046 | -70.1% | 0.01% | -71.1% |
| Q4 2022 | $5,729 | -90.5% | 50,340 | +5255.3% | 0.04% | +4400.0% |
| Q3 2022 | $60,000 | -96.7% | 940 | -95.9% | 0.00% | -93.8% |
| Q2 2022 | $1,812,000 | -23.5% | 22,712 | +0.9% | 0.02% | -5.9% |
| Q1 2022 | $2,368,000 | -8.6% | 22,512 | -18.9% | 0.02% | -10.5% |
| Q4 2021 | $2,590,000 | -33.8% | 27,748 | -22.3% | 0.02% | -20.8% |
| Q3 2021 | $3,912,000 | -0.9% | 35,709 | -15.3% | 0.02% | -4.0% |
| Q2 2021 | $3,947,000 | +1.7% | 42,151 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $3,880,000 | +277.4% | 42,151 | +200.0% | 0.02% | +257.1% |
| Q4 2020 | $1,028,000 | +49.4% | 14,051 | +58.7% | 0.01% | +16.7% |
| Q3 2020 | $688,000 | -64.6% | 8,854 | -74.7% | 0.01% | -66.7% |
| Q2 2020 | $1,945,000 | +211.7% | 34,993 | +66.2% | 0.02% | +157.1% |
| Q1 2020 | $624,000 | -18.1% | 21,060 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $762,000 | +34.9% | 21,060 | +1.4% | 0.01% | +40.0% |
| Q3 2019 | $565,000 | -32.0% | 20,760 | -39.9% | 0.01% | -37.5% |
| Q2 2019 | $831,000 | – | 34,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |